It's time to fight
antimicrobial resistance


IN ORDER TO PREVENT...

...the spread of antimicrobial resistant bacteria there needs to be a significant decrease in antibiotic use in wound care.

While the World Health Organization is addressing AMR with a Global Action Plan, there is a lot of room to contribute to the prevention of AMR in the wound care sector.1 To be truly effective against AMR, action must be taken at every level of wound care, from wound specialists to wound nurses.

The European Wound Management Association recommends avoiding the unnecessary usage of antibiotics through adequate infection prevention/management and appropriate hygiene protocols.2

JOIN THE FIGHT AGAINST AMR

#WOUND_WARRIORS

THE WAY OF A WOUND WARRIOR

BECOME A WOUND WARRIOR AND JOIN THE FIGHT AGAINST ANTIMICROBIAL RESISTANCE

With the right tools for infection prevention and management in wound care, the unnecessary use of antibiotics may be avoidable. Through its brands, Cutimed® and Leukomed®, Essity offers a comprehensive range of wound care products that effectively prevent and manage infection with no known risk of further contributing to antimicrobial resistance.

  • The purely physical mode of action of Sorbact® technology effectively reduces the bacterial load and promotes wound healing
  • No known mechanism of resistance has been described
  • No additional release of endotoxins

FIGHT AGAINST AMR

APPROPIATE WOUND CARE FOR INFECTION PREVENTION AND INFECTION MANAGEMENT CAN PLAY A POWERFUL ROLE IN THE FIGHT AGAINST AMR

Cutimed® and Leukomed® offer an extensive range of effective products in wound management and infection control which may help avoid excessive use of antibiotics in wound care

SORBACT® TECHNOLOGY

Leukomed® Sorbact® and Cutimed® Sorbact® utilize the safe and effective Sorbact® technology that binds bacteria with a purely physical mode of action. Sorbact® Technology removes bacteria without releasing possibly harmful endotoxins3

INFECTION MANAGEMENT WITH CUTIMED®

Advanced chronic wound dressing for safe and effective wound management with a purely physical mode of action

SORBACT® BACTERIA-BINDING TECHNOLOGY
  • Safely binds bacteria and fungi
  • No known mechanism of resistance has been described

CUTIMED® SORBACT® HAS DEMONSTRATED PROVEN EFFECTIVENESS

In a randomized, comparative, single study of 40 patients with leg ulcers, Cutimed® Sorbact® was more effective at reducing bioburden than Aquacel® Ag.8

CUTIMED® SORBACT®

NEW NARRATIVE REVIEW SHOWS 4,044 PATIENTS WERE SUCCESFULLY TREATED IN CLINICAL STUDIES WITH SORBACT® TECHNOLOGY9
  • Wound infection management10 11 12
  • Purely physical mode of action
  • Binds bacteria and fungi13

#WOUND_WARRIORS

An antimicrobial stewardship initiative

LEUKOMED® SORBACT®

LEUKOMED® SORBACT® HAS DEMOSTRATED PROVEN EFFECTIVENESS IN VARIOUS CLINICAL STUDIES4, 7

  • Clinically significant 65% relative risk reduction of acquiring a surgical site infection post caesarean section4
  • Up to 57% cost reduction when treating caesarean sections, using NHS cost model5
  • Effective reduction of the bacterial burden in critically colonized or locally infected wounds6

Innovative surgical post-operative dressing for the reduction of bacterial colonization with a purely physical mode of action.

Indications

All post/operative and traumatic wounds with dry to low exudate levels:

  • Surgical incisions
  • Lacerations, cuts, abrasions

JOIN THE FIGHT AGAINST AMR

#WOUND_WARRIORS

STAND UP AGAINST AMR

WITH A WIDE RANGE OF PRODUCTS INCLUDING SORBACT® TECHNOLOGY FOR PREVENTION AND INFECTION MANAGEMENT IN WOUND CARE, FROM ESSITY

CUTIMED® DEBRICLEAN
CUTIMED® DEBRICLEAN

The innovative, efficient and easy to use debridement compress.

  • Fast and efficient cleaning
  • 99% of biofilm is removed with just 4 swabs
  • Excellent bacterial binding
LEARN MORE
LEUKOMED® SORBACT®
LEUKOMED® SORBACT®

Post-operative surgical dressing for reducing bacterial colonization by means of a purely physical mode of action.

  • Sorbact® bacteria-binding technology
  • Effective prevention of surgical site infections 14 15
  • Bacteria resistant adhesive film
LEARN MORE
LEUKOMED® CONTROL
LEUKOMED® CONTROL

Transparent wound dressing for effective infection risk control.

  • Transparent, conformable film
  • Bacteria-proof film
  • Skin-friendly adhesive
  • Absorbent hydropolymer gel
LEARN MORE
LEUKOPLAST® ANTIMICROBIAL SPOOLS
LEUKOPLAST® ANTIMICROBIAL SPOOLS

Worlds first spools and snap rings that actively combat bacteria.

  • >99% MRSA reduction within 6 hours 16
  • No known mechanism of resistance has been described 16
  • Provide an additional layer of defense in hygiene 17
LEARN MORE
CUTIMED® SORBACT®
CUTIMED® SORBACT®

Infection treatment for chronic wounds using a purely physical mode of action.

  • Sorbact® Bacterial Binding Technology
  • No known resistance mechanism has been described
  • Clinically proven
LEARN MORE
LEUKOMED® CONTROL
LEUKOMED® CONTROL

Transparent wound dressing for effective infection risk control.

  • Transparent, conformable film
  • Bacteria-proof film
  • Skin-friendly adhesive
  • Absorbent hydropolymer gel
LEARN MORE

REFERENCES

  1. World health Organization, Global Action plan on antimicrobial resistance, May 2015.
  2. EWMA document: Antimicrobials and Non-healing Wounds.
  3. As shown in vitro; Susilo YB, Husmark J. DACC Coated. Wound Dressing and Endotoxin: Investigation on Binding Ability and Effect on Endotoxin Release from Gram-negative Bacteria. Poster presented at EWMA 2019.
  4. Stanirowski J, Bizon M, Cendrowski K, et al (2016b) Randomized controlled trial evaluating dialkylcarbomyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing caesarean section. Surg Infect (Larchmt) 17(4): 427 -35.
  5. Stanirowski PJ, Davies H, McMaster J, Mealing S, Sawicki W, Cendrowski K, Posnett J. Cost-effectiveness of a bacterial-binding dressing to prevent surgical site infection following caesarean section. J Wound Care. 2019 Apr 2;28(4):222-228.
  6. Cutting K, Maguire J (2015) Safe bioburden management. A clinical review of DACC technology. Journal of Wound Care Vol 24, No 5.
  7. Bua N, et al. Dlalkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017 Oct:44:387-392.
  8. Mosti et al., Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study, Journal of Wound Care, 2015 Mar;24(3):121-2; 124-7.
  9. Chadwick and Ousey Bacterial-binding dressings in the management of wound healing and infection prevention: a narrative review journal of wound care Vol 28, No 6, June 2019.
  10. Mosti et al., (2015) “Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study”, Journal of Wound Care, 24(3): 121-2; 147-7.
  11. Stanirowski et al. Randomized Controlled Trial Evaluating Dialkylcarbamoyl Chloride Impregnated Dressings for the Prevention of Surgical Site Infections in Adult Women Undergoing Cesarean Section. Surg Infect (Larchmt). 2016 Aug;17(4):427-35.
  12. Totty et al., Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: a systematic review, Vol 26, No 3, March 2017.
  13. Llungh et al Using the principle of hydrophobic interaction to bind and remove wound bacteria, Journal of Wound Care Vol 15, No 4, April 2006
  14. Stanirowski J, Bizon M, Cendrowski K, et al (2016b) Randomized controlled trial evaluating dialkylcarbomyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing caesarean section. Surg Infect (Larchmt) 17(4): 427 -35.
  15. Bua N, et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017 Oct; 44:387-392.
  16. Laboratory studies conducted by SGS Germany GmbH on behalf of BSN Medical GmbH, 2016, internal data.
  17. Struensee B, et al. Determination of the bioburden level of spools of surgical tapes in different medical institutions. Poster presented at EWMA 2017.

Contact information

Essity Belgium SA-NV
Berkenlaan 8B bus 3
1831 Diegem
Belgique

Tel.: +32 (0) 2 766 05 05

Social media